Skip to Content
Morningstar
Get 14 Days Free

US Foods Holding Corp USFD

Morningstar Rating
Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

No-Moat US Foods Is Managing Pandemic Challenges Well, Leaving Shares Modestly Undervalued

Analyst Note

| Rebecca Scheuneman, CFA |

No-moat US Foods reported second-quarter sales of $7.7 billion, a mid-90% of prepandemic sales (adjusted for acquisitions) by our estimate, besting our expectation for sales that represented a high-80% of the pre-crisis level. By channel, restaurants, healthcare facilities, and hospitality sales were at 105%, 90%, and 60% of 2019 sales, with the latter exiting the quarter at over 70%. Although a recent uptick in the number of COVID-19 cases may slow the pace of the recovery, we now think US Foods’ sales will return to its previous peak by early 2022, from late 2022 previously.

Read Full Analysis

Company Profile

Business Description

US Foods is the second- largest U.S. food-service distributor behind Sysco, holding 10% market share of the highly fragmented food-service distribution industry. US Foods distributes more than 400,000 food and nonfood products to the healthcare and hospitality industries (each about 16.5% of sales), independent restaurants (33%), national restaurant chains (22%), education and government facilities (8%), and grocers (4%). In addition to its delivery business, the firm has 80 cash and carry stores under the Chef'Store banner. After Sysco's attempt to purchase US Foods failed to gain federal approval in 2015, US Foods entered the public market via an initial public offering.

Contact
9399 West Higgins Road, Suite 100
Rosemont, IL, 60018
T +1 847 720-8000
Sector Consumer Defensive
Industry Food Distribution
Most Recent Earnings Jun 30, 2021
Fiscal Year End Dec 31, 2020
Stock Type Slow Growth
Employees 26,000

Related

Our Picks
33 Undervalued Stocks
Here are our analysts' top ideas in each sector this quarter.
Susan Dziubinski
US Videos
Pandemic-Focused Buyers Shaped Consumer Defensive's Quarter
Here are two stocks that catch our eye.
Erin Lash
Quarter-End Insights
Consumer Defensive Stocks Now Heated But Opportunities Remain
Tobacco and alcohol look attractive.
Erin Lash
US Videos
Meat Processing Disruptions, Price Inflation to Continue
Our analyst examines the food supply chain, restaurant sales, and attractive shares for one name.
Rebecca Scheuneman
Quarter-End Insights
Consumer Defensive: Uncertainty Creates Attractive Valuations
Tobacco and beverage subsectors look particularly attractive.
Erin Lash

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.